Provided by Tiger Trade Technology Pte. Ltd.

INCANNEX HEALTHCARE LTD

3.57
-0.0500-1.38%
Post-market: 3.54-0.0300-0.84%19:57 EDT
Volume:71.45K
Turnover:256.01K
Market Cap:42.71M
PE:-0.68
High:3.65
Open:3.62
Low:3.51
Close:3.62
52wk High:27.69
52wk Low:2.49
Shares:11.96M
Float Shares:10.50M
Volume Ratio:0.78
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2165
EPS(LYR):-40.8237
ROE:-117.17%
ROA:-32.19%
PB:0.57
PE(LYR):-0.09

Loading ...

Incannex says Phase 2 RePOSA trial shows IHL-42X reduces sleep apnea severity

Reuters
·
May 12

Incannex Healthcare Inc expected to post a loss of 93 cents a share - Earnings Preview

Reuters
·
May 11

Incannex backs White House order to speed access to psychedelic mental health treatments

Reuters
·
Apr 22

Incannex says Phase 2 trial shows PSX-001 cuts GAD anxiety scores vs placebo

Reuters
·
Apr 22

Incannex Healthcare Inc - Psx-001 Shows Statistically Significant Improvements in Phase 2 Trial

THOMSON REUTERS
·
Apr 22

Incannex Healthcare Psx-001 Program Aligns With White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness

THOMSON REUTERS
·
Apr 22

Two new option listings on April 16th

TIPRANKS
·
Apr 16

Incannex reactivates share repurchase program

TIPRANKS
·
Mar 27

BRIEF-Incannex Reactivates Share Repurchase Program, Underscoring Confidence In Valuation And Strategic Position

Reuters
·
Mar 27

Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position

THOMSON REUTERS
·
Mar 27

Incannex enters partnership agreement with American Academy of Sleep Medicine

TIPRANKS
·
Mar 25

Incannex Healthcare joins AASM Foundation Corporate Recognition Program; IHL-42X advances toward potential oral treatment for obstructive sleep apnea

Reuters
·
Mar 25

Incannex reports balance sheet with $75M in cash, no debt

TIPRANKS
·
Mar 18

Incannex Healthcare reports USD 75 million cash balance with no debt

Reuters
·
Mar 18

Incannex regains compliance with Nasdaq minimum bid price rule

TIPRANKS
·
Mar 17

BRIEF-Incannex Regains Compliance With Nasdaq Minimum Bid Price Requirement

Reuters
·
Mar 17

Incannex Healthcare prices USD 10 million registered direct offering

Reuters
·
Mar 12

Incannex to Launch DReAMzz Phase 2 Crossover Dose-Optimization Study for IHL-42X and Advance a Streamlined Phase 3 Program Toward Potential Registration in Obstructive Sleep Apnea

Reuters
·
Mar 12

Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Mar 12

AbbVie Inc Stock Closed Up by 3.12% on Feb 27: What Signal Does It Send?

TradingKey
·
Feb 28